US 6207147
Cancer immunotherapy using tumor cells combined with mixed lymphocytes
expired A61KA61K2039/515A61K2239/31
Quick answer
US patent 6207147 (Cancer immunotherapy using tumor cells combined with mixed lymphocytes) held by The Regents of the University of California expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K2039/515, A61K2239/31, A61K2239/38, A61K2239/47